Concert Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,866
| Closed | -$229K | – | 522 |
|
|
2016
Q4 | $229K | Sell |
1,866
-2,041
| -52% | -$250K | 0.05% | 428 |
|
|
2016
Q3 | $477K | Buy |
3,907
+543
| +16% | +$66.3K | 0.06% | 379 |
|
|
2016
Q2 | $396K | Buy |
3,364
+1,791
| +114% | +$211K | 0.05% | 392 |
|
|
2016
Q1 | $220K | Buy |
1,573
+342
| +28% | +$47.8K | 0.03% | 563 |
|
|
2015
Q4 | $234K | Buy |
+1,231
| New | +$234K | 0.03% | 548 |
|
|
2015
Q3 | – | Sell |
-2,093
| Closed | -$378K | – | 744 |
|
|
2015
Q2 | $378K | Buy |
+2,093
| New | +$378K | 0.05% | 430 |
|
|
2015
Q1 | – | Sell |
-1,917
| Closed | -$354K | – | 645 |
|
|
2014
Q4 | $354K | Buy |
+1,917
| New | +$354K | 0.05% | 403 |
|